Novo Nordisk A/S Sponsored ADR (0TDD)
LSE
Closed
Aug 24, 2026
Day's Range
46.5652 wk Range
35.09Overview - 0TDD - Novo Nordisk A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
47.40B
P/E (Trailing)
‪0.15‬
Price / Book
‪6.02‬
EV / EBITDA
‪1.74‬
Profitability
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
2.41B
Float
3.17B
Held by Insiders
‪0.0030%‬
Held by Institutions
‪9.90%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪116.39‬
200-Day Avg
‪97.55‬
Dividends
Frequency
Semi-Annual
Market Cap - 0TDD - Novo Nordisk A/S Sponsored ADR
Peers - 0TDD - Novo Nordisk A/S Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0TDDLSENovo Nordisk A/S Sponsored ADR113.63BMarket Cap-20.67%52-week change0.16P/E (Trailing)‪35.34%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.02%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0TDD - Novo Nordisk A/S Sponsored ADR
About
Novo Nordisk is a leading global pharmaceutical company headquartered in Denmark that specializes in developing and manufacturing medicines to treat serious chronic diseases. The company focuses on four primary therapeutic areas: diabetes, obesity, cardiovascular disease, and rare diseases including hemophilia and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
